0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-02-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 08359665 2024-02-01 2025-01-31 08359665 2025-01-31 08359665 2024-01-31 08359665 2023-02-01 2024-01-31 08359665 2024-01-31 08359665 2023-01-31 08359665 bus:Director1 2024-02-01 2025-01-31 08359665 core:WithinOneYear 2025-01-31 08359665 core:WithinOneYear 2024-01-31 08359665 core:AfterOneYear 2025-01-31 08359665 bus:Micro-entities 2024-02-01 2025-01-31 08359665 bus:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 08359665 bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 08359665 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 08359665 bus:FullAccounts 2024-02-01 2025-01-31
COMPANY REGISTRATION NUMBER: 08359665
LONDON CLINICARE LIMITED
Filleted Unaudited Financial Statements
31 January 2025
LONDON CLINICARE LIMITED
Statement of Financial Position
31 January 2025
2025
2024
£
£
Fixed assets
2,194
1,459
-------
-------
Current assets
1,382
11,733
Creditors: amounts falling due within one year
10,719
29,412
--------
--------
Net current liabilities
9,337
17,679
-------
--------
Total assets less current liabilities
( 7,143)
( 16,220)
Creditors: amounts falling due after more than one year
12,749
Accruals and deferred income
400
280
--------
--------
(20,292)
(16,500)
--------
--------
Capital and reserves
( 20,292)
( 16,500)
--------
--------
For the year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 29 November 2025 , and are signed on behalf of the board by:
Mrs Patel
Director
Company registration number: 08359665
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 7 Dyson Drive, Uxbridge, UB10 0GJ.